Ascelia Pharma will present Orviglance SPARKLE study primary results as oral presentation in cutting edge research at the 2024 RSNA annual meeting. Timing of presentation: 2 Dec, 13:30-14:00 CDT, local time Chicago  

Magnus Corfitzen will present at ABG Sundal Collier's seminar Investor Day. To register: abgsc investor days seminar 4-5 December Stockholm  

Ascelia Pharma will present at the institutional investor seminar, to register: investor seminar registration